Shinji Kasai's career (active since ~1990) centers on the molecular mechanisms of insecticide resistance in disease vectors. OpenAlex identifies ~192 works with ~5,682 citations and h-index 42; Semantic Scholar-style metrics list h-index 37, 4,944 citations across 128 papers β a discrepancy typical of database splitting/merging, so treat ranges rather than point values as reliable. Peak citation years (2010-2011, ~936/yr) and 2014 (~952/yr) coincide with his most influential first- and co-authored works: the house fly genome and the Aedes aegypti pyrethroid-resistance mechanisms paper .
Figure: OpenAlex reported citation counts by year; 2023-2026 values (28, 38, 79, 4) lag due to indexing delay and should not be read as declining impact.
His portfolio spans five decades of vectors and mechanisms: kdr mutations in Aedes, Culex, head lice, and sandflies; CYP9M10 duplication/cis-regulatory evolution in Culex quinquefasciatus; house fly Vssc alleles; and CRISPR/TALEN-based causal tests of CYP9M10 in resistance . His 2019 management review on Aedes vector resistance is among the field's standard references (374 citations) .
His recent work extends beyond molecular toxicology into vector community ecology. The 2026 study used 16 species, 367 occurrence sites (1 km) and 193 (10 km) over a 10-year Japan survey (2013-2022), with Maxent SDMs (AUC 0.834-0.998) and PGLMMs. Environmental filtering dominated: non-phylogenetic species variance (2.316) dwarfed the phylogenetic component (0.027), and species-specific slope variances for sheep density (2.115), elevation, and human population far exceeded phylogenetic components . This is rigorous, data-rich, well-powered for its scope, but correlational β occurrence data cannot separate plasticity from adaptation, and the COI-only phylogeny limits phylogenetic inference (acknowledged by the authors).
Verdict: an established, high-impact specialist (h-index ~37-42) whose molecular resistance work is field-defining, now credibly pivoting into quantitative community ecology with appropriately disclosed limitations. Confidence: moderate-high on metrics (database discrepancy), high on research content (full-text evidence available).
Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.